- Hologic Board Member, Sally W. Crawford, Recognized As NACD Directorship 100™ Honoree
- Hologic Announces FDA Approval of Aptima® CMV Quant Assay for Human Cytomegalovirus
- Hologic to Webcast Presentation at Upcoming Investor Conference
- Hologic Announces Financial Results for Second Quarter of Fiscal 2022
- American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Now Includes Breast Cancer Index™ to Guide Decisions about Extended Endocrine Therapy
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2022 on Wednesday, April 27, 2022
- Hologic Opens New Innovation Center in France
- S3 Ventures Announces $250M Fund VII – The Largest Venture Capital Fund Focused on Texas-based Startups
- Hologic WTA Tour Swings into Action Ahead of BNP Paribas Open
- Hologic Partners With the WTA Tour in Landmark Title Sponsorship
More ▼
Key statistics
As of last trade Hologic Inc (HOLX:NSQ) traded at 78.00, -3.75% below its 52-week high of 81.04, set on Sep 10, 2021.
52-week range
Markit short selling activity
Open | 77.36 |
---|---|
High | 78.08 |
Low | 76.97 |
Bid | 77.97 |
Offer | 78.03 |
Previous close | 77.55 |
Average volume | 2.05m |
---|---|
Shares outstanding | 249.38m |
Free float | 247.60m |
P/E (TTM) | 12.71 |
Market cap | 19.26bn USD |
EPS (TTM) | 6.07 USD |
Data delayed at least 15 minutes, as of May 19 2022 15:21 BST.
More ▼